Aller au contenu principal
Profil bibliographique

Fenna Scharloo

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
31Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Neutropenia and Cancer InfectionsAntifungal resistance and susceptibilityAntimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and EfficacyStreptococcal Infections and Treatments

Les publications récentes

Accès ouvert 2024 article OpenAlex

Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study

Fenna Scharloo, Francesco Cogliati Dezza, Inmaculada López-Hernández, Pedro María Martínez Pérez-Crespo et autres

PURPOSES: Enterococcal BSI is associated with significant morbidity and mortality, with fatality rates of approximately 20-30%. There are microbiological and clinical differences between E. faecalis and E. faecium infections. The aim of this study was to investigate differences in predisposing factors for …

nl, es, it (code pays fourni par la source)

16 citations European Journal of Clinical Microbiology & Infectious Diseases
Accès ouvert 2024 article OpenAlex

Impact of ciprofloxacin prophylaxis on blood stream infection during early treatment phase of pediatric acute lymphoblastic leukemia: An observational cohort study

Fenna Scharloo, Tom F.W. Wolfs, Tjomme van der Bruggen, Inge Margriet van der Sluis et autres

Purpose Data on the efficacy of antibiotic prophylaxis in children with acute lymphoblastic leukemia (ALL) is scarce and recent guidelines advise against its use. This study is conducted to evaluate if the use of ciprofloxacin prophylaxis is associated with a decrease in …

nl (code pays fourni par la source)

0 citations EJC Paediatric Oncology
Accès ouvert 2022 article OpenAlex

Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature

Yvette G.T. Loeffen, Fenna Scharloo, Bianca F. Goemans, Katja M. J. Heitink‐Pollé et autres

BACKGROUND: Mucormycosis is classified as the third leading cause of invasive fungal disease in immunocompromised patients and is characterized by high morbidity and mortality (33%-56%). The aim of this study is to describe presentation, treatment and outcome of Dutch pediatric hemato-oncology patients …

nl (code pays fourni par la source)

15 citations The Pediatric Infectious Disease Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.